Search Results

Site Search

Research Archives - Page 4 of 33 - Insights

Skip to Content MayoACCESS MayoLINK...

National Stop The Bleed Day - Insights

Pat Hlavka, CSP, Safety Coordinator at Mayo Clinic, talks about the importance of National Stop The Bleed Day, a national awareness campaign about the top cause of preventable death in trauma.

July 2023 - Cytopathology and Pulmonary Pathology - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cytopathology & Pulmonary Pathology.

November 2023 - Laboratory Genetics and Genomics - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Laboratory Genetics and Genomics.

Mayo Clinic Laboratory and Pathology Research Roundup: Dec. 4 - Insights

This week’s Research Roundup highlights extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy.

Membranous nephropathy - Insights

Membranous nephropathy (MN) is one of the leading causes of nephrotic syndrome in adults. Our menu of clinically validated assays assists with diagnosis, monitors disease progression, and guides clinical outcomes.

Chromosomal microarray better informs brain tumor diagnosis - Insights

Molecular biomarkers are a critical component in the treatment of adult and pediatric brain tumors. Robert Jenkins, M.D., Ph.D., explains how Mayo Clinic Laboratories' chromosomal microarray provides more comprehensive and accurate tumor...

Multiple Sclerosis Profile Updates - Insights

Maria Alice Willrich, Ph.D., explains kappa free light chain testing — Mayo Clinic Laboratories' data-driven approach to diagnose multiple sclerosis. The automated assay is more sensitive, cost-effective, and faster than traditional...

Paraneoplastic Vision Loss Evaluation [Test in Focus] - Insights

Andrew McKeon, M,B., B.Ch., M.D., provides an overview of Mayo Clinic Laboratories' new paraneoplastic vision loss evaluation — a test that can help direct a cancer diagnosis and guide treatment. He reviews why this test was developed, when...

Minimal residual disease - Insights

Get full-spectrum minimal residual disease testing options, all from one laboratory, with experts to support testing decisions and results.

Testing Archives - Page 21 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Labor Day Specimen Shipping Guidelines and Schedule - Insights

Mayo Clinic Laboratories specimen pickup and delivery schedules will be altered due to the upcoming holiday. To ensure specimen stability and prevent delays, follow these guidelines.

Colorectal panel provides detailed cancer information - Insights

Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new colorectal cancer panel. The assay covers more genes to better inform decision-making about prognosis, targeted therapies and a hereditary cancer syndrome.

Extended Spectrum Beta Lactamase Testing - Insights

Audrey Schuetz, M.D., provides a detailed overview of Mayo Clinic Laboratories’ new culture-based extended spectrum beta lactamase (ESBL) testing. Used to screen for the presence of multi-drug resistant gram-negative bacteria in donor stool...

Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score - Insights

In this month’s “Hot Topic,” Divyanshu Dubey, M.B.B.S., discusses how patients with encephalopathy and/or epilepsy of unknown etiology may have an autoimmune or paraneoplastic cause.

Antibody Prevalence in Epilepsy and Encephalopathy (APE2) Score - Insights

In this month’s “Hot Topic,” Divyanshu Dubey, M.B.B.S., discusses how patients with encephalopathy and/or epilepsy of unknown etiology may have an autoimmune or paraneoplastic cause.

CPT Codes and LOINC Update: September 2020 - Insights

The following list includes updates posted to mayocliniclabs.com during the month of September

lysosomal-disorders-screen-interpretive.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 12/2024 Lysosomal Disorders Screen Interpretive Algorithm One of the following: ■ α-Mannosidosis ■ Aspartyglucosaminuria ■ β-Mannosidosis ■ Gaucher disease ■...

acute_leukemias_of_ambiguous_lineage_testing_algorithm.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 01/2025 Acute Leukemias of Ambiguous Lineage Testing Algorithm Order the following: ■ LCMS / Leukemia/Lymphoma Immunophenotyping, Flow Cytometry, Varies ■...

MCL Hereditary Hemorrhagic Telangiectasia and Vascular Malformations Gene Panel Patient Information MC1235296

MCL Hereditary Hemorrhagic Telangiectasia Vascular Malformations Gene Panel Patient Information Complete print Reset Form Hereditary Hemorrhagic Telangiectasia Vascular Malformations Gene Panel Patient Information Instructions Accurate...

international-shipping-guide-spanish.pdf

G U ÍA PARA EN VÍO S IN TERN AC IO N ALES ENVÍO DE PRUEBAS A MAYO CLINIC DESDE CUALQUIER PARTE DEL MUNDO 2 | GUÍA PARA ENVÍOS INTERNACIONALES GUÍA DE ENVÍOS PARA ESTADOS UNIDOS | 2 ÍNDICE REALICE ENVÍOS DESDE CUALQUIER PARTE DEL...

The Secrets of Cryoprecipitate: A Blood Banking Process - Insights

In this month’s “Hot Topic,” Jessie Swanson and Michelle Soland from the Component Laboratory will discuss the process improvement that helped decrease the standard cryoprecipitate dosage and the positive impact it has on patients.

infectious_endocarditis_diagnostic_testing_for_identification_of_microbiological_etiology.pdf

© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 08/2023 This algorithm is intended for use in patients with clinical and/or echocardiographic findings suggestive of infective endocarditis, based on the...

MCL Hereditary Cardiomyopathies and Arrhythmias Patient Information MC1235207

MCL Hereditary Cardiomyopathies Arrhythmias Patient Information Complete print Hereditary Cardiomyopathies Arrhythmias Patient Information Reset Form Instructions Accurate interpretation reporting genetic results

Defying all odds and exploring a remarkable journey beyond diagnosis: Mike Knudson - Insights

In August of 2021, 28-year-old Mike Knudson, a Twin Cities resident known for his vibrant and active lifestyle, set out on what he anticipated to be an adventurous hiking vacation to the picturesque Glacier National Park in Montana. Little...

What's New in Health Care Reform: Dec.12 - Insights

Top highlights include: how hospitals are fighting burnout, U.S. health spending hits $3.5 trillion but growth slows, why states might start taxing opioids, telemedicine in reverse. and health care providers are teaming with chatbots to...

How to Cut Costs without Cutting Corners - Insights

Nicole Folken, Education Specialist at Mayo Medical Laboratories, discusses how to cut costs without cutting corners when planning a conference or meeting.

The Adoption of Social Media in Education - Insights

Elissa Hall, Associate Director for Curriculum and Education Technology and an Assistant Professor at Mayo Clinic, discusses how the adoption of social media in education creates a flexible environment for facilitating collaborative, deeper...

Immunobullous Diseases: Paraneoplastic Pemphigus (PNP) - Insights

In this month’s “Hot Topic,” Julia Lehman, M.D., will discuss a rare and potentially fatal mucocutaneous blistering disease that is often associated with an underlying malignancy, called paraneoplastic pemphigus. She will also discuss the...

Carrier Screening [Test in Focus] - Insights

Michelle Kluge, M.S., CGC, explains how Mayo Clinic Laboratories’ CYPZ assay provides accurate testing for congenital adrenal hyperplasia. Using an in-depth methodology that incorporates Sanger sequencing, MCL can provide clear answers for...

Novel biomarkers added to movement disorders profile - Insights

Andrew McKeon, M.B., B.Ch., M.D., explains how Mayo Clinic Laboratories' expanded movement disorders panel better identifies autoimmune conditions to guide appropriate treatment.

MayoComplete Solid Tumor Panel - Insights

Kevin Halling, M.D., Ph.D., explains how the MayoComplete Solid Tumor panel uses next-generation sequencing to assess 514 clinically significant, cancer-related genes for genetic alterations that offer insight on treatment effectivity.

Congenital disorders of glycosylation - Insights

In this month’s “Hot Topic,” Gessi Pino, a genetic counselor in the Biochemical Genetics Lab at Mayo Clinic, and Kimiyo Raymond, M.D., a clinical consultant in the laboratory and an expert in Congenital Disorders of Glycosylation (CDG),...

MCL Congenital Heart Disease Genetic Testing Patient Information MC1235298

MCL Congenital Heart Disease Genetic Testing Patient Information Complete print Reset Form Congenital Heart Disease Genetic Testing Patient Information Instructions Accurate interpretation reporting genetic results

Pathways Case Studies: July 2022 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for July include the following sub-specialties: Gastroenterology Pathology,...

NY State Informed Consent Tests - Mayo Clinic Laboratories

NY State Informed Consent Tests New York State clients are required by New York State regulations to have completed informed-consent forms on file. When ordering the following tests, all NYS clients are required to indicate to...

IMPACTS Team Continues to Combat Life-Threatening Arthropod-Borne Infections in Belize - Insights

Now in its second year of a five-year initiative to better understand and detect arboviruses in Belize, the IMPACTS (Integrated Mayo Clinic Program for Arbovirus Community health education Training and Surveillance) project has expanded its...

MCL Molecular Genetics Neurology Patient Information MC1235235

MCL Molecular Genetics Neurology Patient Information Complete print Molecular Genetics Neurology Patient Information Reset Form Instructions accurate interpretation reporting genetic results

Frequently asked questions - Insights

Check out the answers to the most frequently asked questions about pharmacogenomic testing at Mayo Clinic Laboratories.

Precision oncology therapeutics - Insights

Learn more about our personalized cancer testing that establishes patients’ genetic profiles and allows physicians to select medications that optimize therapeutic efficacy while minimizing harmful reactions.

Inborn errors of metabolism - Insights

Learn more about how Mayo Clinic Laboratories’ comprehensive menu of biochemical and molecular testing can diagnose inborn errors of metabolism.

Myeloproliferative neoplasms - Insights

Learn about our reflexive molecular testing protocols that are designed to guide proper utilization of myeloproliferative neoplasms.

Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D. - Insights

Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage.

PIK3CA assay guides treatment of progressing breast cancer - Insights

Katherine Geiersbach, M.D., explains how Mayo Clinic Laboratories' PIK3CA assay informs breast cancer treatment. The assay identifies patients eligible for a certain second-line therapy when initial treatment has failed.

Pathways Case Studies: November 2023 - Insights

This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for November include the following sub-specialties: Cardiovascular Pathology,...

search - Mayo Clinic Laboratories

Search Results Test Catalog...